4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Remifentanil is combined with Gamma Hydroxybutyric Acid.
Acebutolol
Remifentanil may increase the bradycardic activities of Acebutolol.
Acepromazine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Acepromazine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Aceprometazine.
Acetazolamide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Acetazolamide.
Aclidinium
The risk or severity of adverse effects can be increased when Aclidinium is combined with Remifentanil.
Advertisement
Aldesleukin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Aldesleukin.
Alfaxalone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Remifentanil.
Advertisement
Aliskiren
The risk or severity of adverse effects can be increased when Remifentanil is combined with Aliskiren.
Alphaprodine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Remifentanil.
Alprenolol
Remifentanil may increase the bradycardic activities of Alprenolol.
Alvimopan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Alvimopan.
Alvimopan Anhydrous
The risk or severity of adverse effects can be increased when Remifentanil is combined with Alvimopan.
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Remifentanil.
Amifostine Anhydrous
The risk or severity of adverse effects can be increased when Amifostine is combined with Remifentanil.
Amiloride
The risk or severity of adverse effects can be increased when Remifentanil is combined with Amiloride.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Remifentanil.
Amisulpride
The risk or severity of adverse effects can be increased when Remifentanil is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Remifentanil is combined with Amitriptyline.
Amlodipine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Amlodipine.
Ammonium Chloride
Ammonium chloride may increase the excretion rate of Remifentanil which could result in a lower serum level and potentially a reduction in efficacy.
Amobarbital
The risk or severity of adverse effects can be increased when Remifentanil is combined with Amobarbital.
Amoxapine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Amoxapine.
Amphetamine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Amphetamine.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Remifentanil.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Remifentanil.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Remifentanil is combined with Amyl Nitrite.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Remifentanil.
Apraclonidine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Apraclonidine.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Remifentanil.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Remifentanil.
Articaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Asenapine.
Atenolol
Remifentanil may increase the bradycardic activities of Atenolol.
Atracurium
The risk or severity of adverse effects can be increased when Atracurium is combined with Remifentanil.
Atracurium Besylate
The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Remifentanil.
Atropine
The risk or severity of adverse effects can be increased when Atropine is combined with Remifentanil.
Azelastine
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azilsartan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Azilsartan medoxomil.
Azosemide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Azosemide.
Baclofen
The risk or severity of adverse effects can be increased when Remifentanil is combined with Baclofen.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Remifentanil.
Barbital
The risk or severity of adverse effects can be increased when Remifentanil is combined with Barbital.
Benactyzine
The risk or severity of adverse effects can be increased when Benactyzine is combined with Remifentanil.
Benazepril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Benazepril.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Bendroflumethiazide.
Benoxinate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Benzocaine.
Benzphetamine
Benzphetamine may increase the analgesic activities of Remifentanil.
Benztropine
The risk or severity of adverse effects can be increased when Benzatropine is combined with Remifentanil.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Benzyl alcohol.
Bepridil
The risk or severity of adverse effects can be increased when Bepridil is combined with Remifentanil.
Betaxolol
Remifentanil may increase the bradycardic activities of Betaxolol.
Biperiden
The risk or severity of adverse effects can be increased when Biperiden is combined with Remifentanil.
Bisoprolol
Remifentanil may increase the bradycardic activities of Bisoprolol.
Bopindolol
Remifentanil may increase the bradycardic activities of Bopindolol.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Remifentanil.
Bretylium
The risk or severity of adverse effects can be increased when Remifentanil is combined with Bretylium.
Brexpiprazole
The risk or severity of adverse effects can be increased when Remifentanil is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Bromazepam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Bromazepam.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Remifentanil.
Bromperidol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Brotizolam.
Bumetanide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Bupivacaine.
Bupranolol
Remifentanil may increase the bradycardic activities of Bupranolol.
Buprenorphine
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Remifentanil.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Remifentanil.
Butalbital
The risk or severity of adverse effects can be increased when Remifentanil is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Remifentanil is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Remifentanil is combined with Butethal.
Butorphanol
Butorphanol may decrease the analgesic activities of Remifentanil.
Butylscopolamine
The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Remifentanil.
Canagliflozin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Remifentanil is combined with Canagliflozin.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Candesartan cilexetil.
Canrenoate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Canrenoic acid.
Canrenoic Acid
The risk or severity of adverse effects can be increased when Remifentanil is combined with Canrenoic acid.
Canrenone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Canrenone.
Captopril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Captopril.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Remifentanil.
Carbinoxamine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Carisoprodol.
Carteolol
Remifentanil may increase the bradycardic activities of Carteolol.
Carvedilol
Remifentanil may increase the bradycardic activities of Carvedilol.
Celiprolol
Remifentanil may increase the bradycardic activities of Celiprolol.
Cetirizine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Remifentanil.
Chlormethiazole
The risk or severity of adverse effects can be increased when Remifentanil is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chloroprocaine.
Chlorothiazide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chlorothiazide.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chlorphenamine.
Chlorphenoxamine
The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Remifentanil.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Remifentanil.
Chlorprothixene
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chlorprothixene.
Chlorthalidone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chlorthalidone.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Chlorzoxazone.
Cicletanine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cicletanine.
Cilazapril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cilazapril.
Citalopram
Remifentanil may increase the serotonergic activities of Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Clemastine.
Clevidipine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Clevidipine.
Clidinium
The risk or severity of adverse effects can be increased when Remifentanil is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Clobazam.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Remifentanil.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Remifentanil.
Clonazepam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Clonidine.
Clopamide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Clopamide.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Remifentanil.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Remifentanil.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Remifentanil.
Cocaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Remifentanil.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Remifentanil.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Remifentanil.
Conivaptan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Conivaptan.
Cyclizine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cyclobenzaprine.
Cyclopenthiazide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cyclopenthiazide.
Cyclopentolate
The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Remifentanil.
Cyclothiazide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cyclothiazide.
Cyproheptadine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cyproheptadine.
Dantrolene
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dantrolene.
Dapagliflozin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dapagliflozin.
Dapiprazole
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dapiprazole.
Darifenacin
The risk or severity of adverse effects can be increased when Darifenacin is combined with Remifentanil.
Desflurane
The risk or severity of adverse effects can be increased when Remifentanil is combined with Desflurane.
Desipramine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Remifentanil.
Desmopressin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Desmopressin.
Desvenlafaxine
Remifentanil may increase the serotonergic activities of Desvenlafaxine.
Deutetrabenazine
The risk or severity of sedation and somnolence can be increased when Remifentanil is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dexbrompheniramine.
Dexetimide
The risk or severity of adverse effects can be increased when Dexetimide is combined with Remifentanil.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dexmedetomidine.
Dextroamphetamine
Dextroamphetamine may increase the analgesic activities of Remifentanil.
Dextromoramide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Remifentanil.
Dibucaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cinchocaine.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Diclofenamide.
Dicyclomine
The risk or severity of adverse effects can be increased when Dicyclomine is combined with Remifentanil.
Diethylpropion
Diethylpropion may increase the analgesic activities of Remifentanil.
Difenoxin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dihydrocodeine.
Diltiazem
Remifentanil may increase the bradycardic activities of Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dimenhydrinate.
Dinutuximab
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dinutuximab.
Diphenhydramine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Diphenoxylate.
Dipyridamole
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dipyridamole.
Doxazosin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Doxazosin.
Doxepin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Doxepin.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Drospirenone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Drospirenone.
Duloxetine
Remifentanil may increase the orthostatic hypotensive activities of Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Remifentanil is combined with Efavirenz.
Eluxadoline
Remifentanil may increase the constipating activities of Eluxadoline.
Empagliflozin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Empagliflozin.
Enalapril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Remifentanil.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Remifentanil.
Enflurane
The risk or severity of adverse effects can be increased when Remifentanil is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Entacapone.
Eplerenone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Eplerenone.
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Remifentanil.
Eprosartan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Eprosartan.
Escitalopram
Remifentanil may increase the serotonergic activities of Escitalopram.
Esmolol
Remifentanil may increase the bradycardic activities of Esmolol.
Estazolam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Estazolam.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Remifentanil.
Ethacrynate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Remifentanil is combined with Etacrynic acid.
Ethanol
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Etomidate.
Ezogabine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Felbamate.
Felodipine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Felodipine.
Fenoldopam
The risk or severity of adverse effects can be increased when Fenoldopam is combined with Remifentanil.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Remifentanil.
Fesoterodine
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Remifentanil.
Fexofenadine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Fexofenadine.
Flibanserin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Flibanserin.
Flunarizine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Flunitrazepam.
Fluoxetine
Remifentanil may increase the serotonergic activities of Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Remifentanil.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Remifentanil.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Remifentanil.
Fluspirilene
The risk or severity of adverse effects can be increased when Remifentanil is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Fluticasone propionate.
Fluvoxamine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Fluvoxamine.
Fosinopril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Fosinopril.
Fosphenytoin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Fospropofol.
Furazolidone
Furazolidone may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Remifentanil.
Furosemide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Furosemide.
Gabapentin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Gabapentin Enacarbil.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Gallamine Triethiodide is combined with Remifentanil.
Glutethimide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Glutethimide.
Glycopyrronium
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Remifentanil.
Guanfacine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Remifentanil.
Halothane
The risk or severity of adverse effects can be increased when Remifentanil is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Remifentanil is combined with Hexobarbital.
Homatropine
The risk or severity of adverse effects can be increased when Homatropine is combined with Remifentanil.
Hydralazine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Hydralazine.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Hydrochlorothiazide.
Hydrocodone
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Hydroflumethiazide.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Remifentanil.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Hyoscyamine
The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Remifentanil.
Iloperidone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Remifentanil.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Remifentanil.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Remifentanil.
Indapamide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Indapamide.
Indoramin
The risk or severity of adverse effects can be increased when Indoramin is combined with Remifentanil.
Ipratropium Bromide
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Remifentanil.
Ipratropium Bromide Anhydrous
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Remifentanil.
Iproniazid
Iproniazid may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Remifentanil.
Irbesartan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Irbesartan.
Isocarboxazid
The risk or severity of adverse effects can be increased when Remifentanil is combined with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Remifentanil.
Isosorbide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Isosorbide.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Isoxsuprine.
Isradipine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Isradipine.
Ketamine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ketazolam.
Labetalol
Remifentanil may increase the bradycardic activities of Labetalol.
Lacidipine
Remifentanil may increase the hypotensive activities of Lacidipine.
Lamotrigine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Lamotrigine.
Lercanidipine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Remifentanil.
Levetiracetam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Levetiracetam.
Levobunolol
Remifentanil may increase the bradycardic activities of Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Levocetirizine.
Levodopa
Remifentanil may increase the orthostatic hypotensive activities of Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Remifentanil is combined with Levomethadyl Acetate.
Levomilnacipran
Remifentanil may increase the serotonergic activities of Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Remifentanil.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Remifentanil.
Lidocaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Lidocaine.
Lisdexamfetamine
Lisdexamfetamine may increase the analgesic activities of Remifentanil.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may increase the analgesic activities of Remifentanil.
Lisinopril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Remifentanil is combined with Lisinopril.
Lithium
The risk or severity of adverse effects can be increased when Remifentanil is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Remifentanil is combined with Lithium.
Lofexidine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Remifentanil.
Loratadine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Remifentanil.
Lormetazepam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Lormetazepam.
Losartan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Losartan.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Remifentanil.
Lurasidone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Lurasidone.
Magnesium Sulfate
The therapeutic efficacy of Remifentanil can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Remifentanil can be increased when used in combination with Magnesium sulfate.
Mannitol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Mannitol.
Maprotiline
The risk or severity of adverse effects can be increased when Remifentanil is combined with Maprotiline.
Mecamylamine
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Remifentanil.
Meclizine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Remifentanil.
Mephentermine
Mephentermine may increase the analgesic activities of Remifentanil.
Mephobarbital
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methylphenobarbital.
Mepirodipine
The risk or severity of adverse effects can be increased when Barnidipine is combined with Remifentanil.
Mepivacaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Remifentanil.
Mersalyl
The risk or severity of adverse effects can be increased when Remifentanil is combined with Mersalyl.
Mesoridazine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Remifentanil.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methadyl Acetate.
Methamphetamine
Methamphetamine may increase the analgesic activities of Remifentanil.
Methantheline
The risk or severity of adverse effects can be increased when Methantheline is combined with Remifentanil.
Methapyrilene
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methaqualone.
Methazolamide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methazolamide.
Methixene
The risk or severity of adverse effects can be increased when Metixene is combined with Remifentanil.
Methocarbamol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Remifentanil.
Methotrimeprazine
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methoxyflurane.
Methscopolamine Bromide
The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Remifentanil.
Methsuximide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methsuximide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methyclothiazide.
Methyldopa
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methyldopa.
METHYLDOPA ANHYDROUS
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methyldopa.
Methylene blue
The risk or severity of adverse effects can be increased when Remifentanil is combined with Methylene blue.
Metipranolol
Remifentanil may increase the bradycardic activities of Metipranolol.
Metolazone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Metolazone.
Metoprolol
Remifentanil may increase the bradycardic activities of Metoprolol.
Metylperon
The risk or severity of adverse effects can be increased when Remifentanil is combined with Melperone.
Metyrosine
Remifentanil may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Remifentanil.
Milnacipran
Remifentanil may increase the serotonergic activities of Milnacipran.
Minaprine
Minaprine may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Remifentanil.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Minoxidil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Minoxidil.
Mirtazapine
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moclobemide
Moclobemide may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Remifentanil.
Moexipril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Moexipril.
Molindone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Molindone.
Moricizine
Moricizine may increase the hypotensive activities of Remifentanil.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Remifentanil.
Moxonidine
The risk or severity of adverse effects can be increased when Moxonidine is combined with Remifentanil.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Nadolol
Remifentanil may increase the bradycardic activities of Nadolol.
Nalbuphine
Nalbuphine may decrease the analgesic activities of Remifentanil.
Naltrexone
The therapeutic efficacy of Remifentanil can be decreased when used in combination with Naltrexone.
Nebivolol
Remifentanil may increase the bradycardic activities of Nebivolol.
Nefazodone
Remifentanil may increase the serotonergic activities of Nefazodone.
Nesiritide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nesiritide.
Nialamide
Nialamide may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Remifentanil.
Nicardipine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nicardipine.
Nicorandil
Nicorandil may increase the hypotensive activities of Remifentanil.
Nifedipine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nifedipine.
Nilvadipine
The risk or severity of adverse effects can be increased when Nilvadipine is combined with Remifentanil.
Nimodipine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nimodipine.
Nisoldipine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nisoldipine.
Nitrazepam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nitrazepam.
Nitrendipine
The risk or severity of adverse effects can be increased when Nitrendipine is combined with Remifentanil.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Remifentanil.
Nitroglycerin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nitroglycerin.
Nitroprusside
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nitroprusside.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nitrous oxide.
Norflurane
The risk or severity of adverse effects can be increased when Remifentanil is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nortriptyline.
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Remifentanil.
Octotropine Methylbromide
The risk or severity of adverse effects can be increased when Anisotropine Methylbromide is combined with Remifentanil.
Octylonium
The risk or severity of adverse effects can be increased when Otilonium is combined with Remifentanil.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Remifentanil.
Olmesartan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Olmesartan.
Olopatadine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Olopatadine.
Ondansetron
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Remifentanil is combined with Opium.
Orphenadrine
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Remifentanil.
Oxitropium
The risk or severity of adverse effects can be increased when Oxitropium is combined with Remifentanil.
Oxprenolol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Oxprenolol.
Oxybutynin
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Remifentanil.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Remifentanil.
Oxymorphone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Oxymorphone.
Oxyphenonium
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Remifentanil.
p-Hydroxyamphetamine
Hydroxyamphetamine may increase the analgesic activities of Remifentanil.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Remifentanil.
Paliperidone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Paliperidone.
Pamabrom
The risk or severity of adverse effects can be increased when Remifentanil is combined with Pamabrom.
Pancuronium
The risk or severity of adverse effects can be increased when Pancuronium is combined with Remifentanil.
Pancuronium Bromide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Remifentanil.
Papaverine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Papaverine.
Paraldehyde
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Remifentanil.
Pargyline
Pargyline may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Remifentanil.
Paroxetine
Remifentanil may increase the serotonergic activities of Paroxetine.
Pegvisomant
The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Remifentanil.
Penbutolol
Remifentanil may increase the bradycardic activities of Penbutolol.
Pentazocine
Pentazocine may decrease the analgesic activities of Remifentanil.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Remifentanil.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Perazine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Perazine.
Periciazine
Propericiazine may increase the hypotensive activities of Remifentanil.
Perindopril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Perindopril.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Remifentanil.
Phenelzine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Phenelzine.
Phenobarbital
The risk or severity of adverse effects can be increased when Remifentanil is combined with Phenobarbital.
Phenoxybenzamine
The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Remifentanil.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Phenoxyethanol.
Phentermine
Phentermine may increase the analgesic activities of Remifentanil.
PHENTERMINE RESIN
Phentermine may increase the analgesic activities of Remifentanil.
Phentolamine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Remifentanil.
Phentolamine Mesylate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Remifentanil.
Phenytoin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Pimozide.
Pindolol
Remifentanil may increase the bradycardic activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Pipamperone.
Pipecuronium
The risk or severity of adverse effects can be increased when Pipecuronium is combined with Remifentanil.
Pipothiazine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Pipotiazine.
Pirenzepine
The risk or severity of adverse effects can be increased when Pirenzepine is combined with Remifentanil.
Piretanide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Piretanide.
Pirinitramide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Remifentanil is combined with Pizotifen.
Polythiazide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Polythiazide.
Pomalidomide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Pomalidomide.
Potassium
The risk or severity of adverse effects can be increased when Remifentanil is combined with Potassium.
Potassium Citrate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Potassium Citrate.
Practolol
Remifentanil may increase the bradycardic activities of Practolol.
Pramipexole
Remifentanil may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Prazepam.
Prazosin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Prazosin.
Pregabalin
The therapeutic efficacy of Remifentanil can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Prilocaine.
Primidone
Primidone may increase the hypotensive activities of Remifentanil.
Procaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Procarbazine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Remifentanil.
Procyclidine
The risk or severity of adverse effects can be increased when Procyclidine is combined with Remifentanil.
Profenamine
The risk or severity of adverse effects can be increased when Ethopropazine is combined with Remifentanil.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Remifentanil.
Promethazine
Promethazine may increase the hypotensive activities of Remifentanil.
Propantheline
The risk or severity of adverse effects can be increased when Propantheline is combined with Remifentanil.
Propantheline Bromide
The risk or severity of adverse effects can be increased when Propantheline is combined with Remifentanil.
Proparacaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Proparacaine.
Propiverine
The risk or severity of adverse effects can be increased when Propiverine is combined with Remifentanil.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Remifentanil.
Propoxyphene
The risk or severity of adverse effects can be increased when Remifentanil is combined with Dextropropoxyphene.
Propranolol
Remifentanil may increase the bradycardic activities of Propranolol.
Protriptyline
The risk or severity of adverse effects can be increased when Remifentanil is combined with Protriptyline.
Pseudoephedrine
Pseudoephedrine may increase the analgesic activities of Remifentanil.
Quazepam
The risk or severity of adverse effects can be increased when Remifentanil is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Quetiapine.
Quinapril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Quinapril.
Quinethazone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Quinethazone.
Quinidine
The risk or severity of adverse effects can be increased when Quinidine is combined with Remifentanil.
Ramelteon
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ramelteon.
Ramipril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ramipril.
Rasagiline
The risk or severity of adverse effects can be increased when Remifentanil is combined with Rasagiline.
Remoxipride
The risk or severity of adverse effects can be increased when Remifentanil is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Remifentanil.
Rilpivirine
The serum concentration of Remifentanil can be decreased when it is combined with Rilpivirine.
Riociguat
The risk or severity of adverse effects can be increased when Remifentanil is combined with Riociguat.
Risperidone
Remifentanil may increase the hypotensive activities of Risperidone.
Ropinirole
Remifentanil may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ropivacaine.
Rotigotine
Remifentanil may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Remifentanil.
Sacubitril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Sacubitril.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Remifentanil.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Remifentanil.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Remifentanil.
Selegiline
The risk or severity of adverse effects can be increased when Remifentanil is combined with Selegiline.
Sertindole
The risk or severity of adverse effects can be increased when Remifentanil is combined with Sertindole.
Sertraline
Remifentanil may increase the serotonergic activities of Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Remifentanil is combined with Sevoflurane.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Solifenacin
The risk or severity of adverse effects can be increased when Solifenacin is combined with Remifentanil.
Sotalol
Remifentanil may increase the bradycardic activities of Sotalol.
Spironolactone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Spironolactone.
Streptokinase
The risk or severity of adverse effects can be increased when Remifentanil is combined with Streptokinase.
Succinylcholine
Succinylcholine may increase the bradycardic activities of Remifentanil.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Remifentanil.
Sulpiride
The risk or severity of adverse effects can be increased when Remifentanil is combined with Sulpiride.
Suvorexant
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Talinolol
Remifentanil may increase the bradycardic activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tamsulosin.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Tasimelteon
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tasimelteon.
Telmisartan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Telmisartan.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Remifentanil.
Terazosin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Terazosin.
Tetrabenazine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Thalidomide
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theobromine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Theobromine.
Thiamylal
The risk or severity of adverse effects can be increased when Remifentanil is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Remifentanil.
Thiopental
The risk or severity of adverse effects can be increased when Remifentanil is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Remifentanil is combined with Thiopental.
Thioproperazine
Thioproperazine may increase the hypotensive activities of Remifentanil.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Remifentanil.
Thiothixene
The risk or severity of adverse effects can be increased when Remifentanil is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tiapride.
Timolol
Remifentanil may increase the bradycardic activities of Timolol.
Timolol Anhydrous
Remifentanil may increase the bradycardic activities of Timolol.
Tiotropium
The risk or severity of adverse effects can be increased when Tiotropium is combined with Remifentanil.
Tizanidine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tizanidine.
Tolazoline
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tolazoline.
Tolcapone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tolcapone.
Toloxatone
Toloxatone may increase the central nervous system depressant (CNS depressant) and hypertensive activities of Remifentanil.
Tolterodine
The risk or severity of adverse effects can be increased when Tolterodine is combined with Remifentanil.
Tolvaptan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tolvaptan.
Topiramate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Topiramate.
Torsemide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Torasemide.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Remifentanil.
Trandolapril
The risk or severity of adverse effects can be increased when Remifentanil is combined with Trandolapril.
Tranylcypromine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Trazodone.
Tretinoin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tretinoin.
Triamterene
The risk or severity of adverse effects can be increased when Remifentanil is combined with Triamterene.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Remifentanil.
Triazulenone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Loprazolam.
Trichlormethiazide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Trichlormethiazide.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Remifentanil.
Triflupromazine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Triflupromazine.
Trihexyphenidyl
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Remifentanil.
Trihexyphenidyl Hydrochloride
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Remifentanil.
Trimeprazine
Alimemazine may increase the hypotensive activities of Remifentanil.
Trimethaphan
The risk or severity of adverse effects can be increased when Trimethaphan is combined with Remifentanil.
Trimipramine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Triprolidine.
Tropicamide
The risk or severity of adverse effects can be increased when Tropicamide is combined with Remifentanil.
Trospium
The risk or severity of adverse effects can be increased when Trospium is combined with Remifentanil.
Tubocurarine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Remifentanil.
Umeclidinium
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Remifentanil.
Urethane
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Remifentanil is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Remifentanil is combined with Valproic Acid.
Valsartan
The risk or severity of adverse effects can be increased when Remifentanil is combined with Valsartan.
Vecuronium
The risk or severity of adverse effects can be increased when Vecuronium is combined with Remifentanil.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Remifentanil.
Venlafaxine
Remifentanil may increase the serotonergic activities of Venlafaxine.
Verapamil
Remifentanil may increase the bradycardic activities of Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Remifentanil is combined with Vigabatrin.
Vortioxetine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Vortioxetine.
Zaleplon
The risk or severity of adverse effects can be increased when Remifentanil is combined with Zaleplon.
Ziconotide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Ziconotide.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Remifentanil.
Zolpidem
Remifentanil may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Remifentanil is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Remifentanil is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Remifentanil is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Remifentanil is combined with Zuclopenthixol.
